US Patent 11535868 Miniaturized dystrophins having spectrin fusion domains and uses thereof
Patent 11535868 was granted and assigned to Bristol-Myers Squibb on December, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Glen Banks0
Jonathan Harry Davis0
Paul Charles Levesque0
Edits on 26 Apr, 2023
Golden AI
Edits on 6 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 4 Apr, 2023
Golden AI
Infobox
Edits on 31 Mar, 2023
Golden AI
Infobox
Edits on 28 Mar, 2023
Golden AI
Edits on 23 Mar, 2023
Golden AI
Edits on 28 Dec, 2022
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+247 characters)
US Patent 11535868 Miniaturized dystrophins having spectrin fusion domains and uses thereof
Article
Disclosed herein are nucleic acid molecules, polypeptides, cells, vectors, and pharmaceutical compositions relating to miniaturized dystrophin. Methods of production and methods of therapeutic use of the miniaturized dystrophin are also disclosed.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
115358680
Date of Patent
December 27, 2022
0Patent Application Number
172423570
Date Filed
April 28, 2021
0Patent Citations
0
Patent Primary Examiner
Find more entities like US Patent 11535868 Miniaturized dystrophins having spectrin fusion domains and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
